|
Hemodynamic parameters, and calcium and magnesium levels |
||||||
| Period after sedative infusion |
||||||
|
|
||||||
| Parameter/level |
Baseline |
Immediately after |
2 hours |
4 hours |
6 hours |
24 hours |
|
|
||||||
| Heart rate (beats/min) |
||||||
| Group 1 |
90 ± 12 |
89 ± 11 |
88 ± 12 |
90 ± 13 |
92 ± 11 |
91 ± 13 |
| Group 2 |
88 ± 11 |
91 ± 9 |
89 ± 11 |
88 ± 12 |
90 ± 12 |
88 ± 12 |
| Mean arterial pressure (mmHg) |
||||||
| Group 1 |
74.1 ± 9.2 |
73.5 ± 14 |
76.3 ± 9.5 |
77 ± 12.5 |
75 ± 12.5 |
75 ± 8.5 |
| Group 2 |
75.2 ± 8.8 |
74 ± 10.7 |
76.4 ± 12.0 |
74 ± 14.8 |
74 ± 14.8 |
73 ± 9.8 |
| Calcium (8.9–10.3 mg/dl) |
||||||
| Group 1 |
9.2 ± 1.1 |
9.1 ± 1.2 |
9.0 ± 1.3 |
|||
| Group 2 |
9.1 ± 1.3 |
8.9 ± 1.1 |
8.9 ± 1.2 |
|||
| Magnesium (1.8–3.5 mg/dl) |
||||||
| Group 1 |
3.06 ± 0.83 |
3.07 ± 0.79 |
3.08 ± 0.68 |
|||
| Group 2 |
2.97 ± 0.95 |
4.0 ± 1.31 |
3.1 ± 0.73 |
|||
|
There were no statistically significant differences between groups (P > 0.05). Group 1 (n = 15) received sufentanil infusion alone, whereas group 2 (n = 15) received sufentanil plus magnesium sulphate. Values are expressed as means ± standard deviation. | ||||||
Memiş et al. Critical Care 2003 7:R123 doi:10.1186/cc2365 |
||||||